Article Information
History
- June 29, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Stephanie A. Leonard1,
- Yasushi Ogawa2,
- Paul T. Jedrzejewski2,
- Soheila J. Maleki3,
- Martin D. Chapman4,
- Stephen A. Tilles2,*,
- George Du Toit5,
- S. Shahzad Mustafa6 and
- Brian P. Vickery7
- 1Division of Pediatric Allergy & Immunology, University of California San Diego, Rady Children’s Hospital, San Diego, CA, United States
- 2Aimmune Therapeutics, a Nestlé Health Science company, Brisbane, CA, United States
- 3United States Department of Agriculture, Agricultural Research Service, New Orleans, LA, United States
- 4Indoor Biotechnologies Inc, Charlottesville, VA, United States
- 5Guy’s and St Thomas’ NHS Foundation Trust, London, United Kingdom
- 6Rochester Regional Health, University of Rochester School of Medicine and Dentistry, Rochester, NY, United States
- 7Emory University School of Medicine, Atlanta, GA, United States
- ↵*Corresponding author
stilles{at}aimmune.com